DigeHealth closes CHF 1.25M Seed Round for gastrointestinal health solutions
09.12.2025
Swiss medtech startup DigeHealth has raised CHF 1.25 million in a seed funding round, providing a strong foundation to develop its next-generation gastrointestinal (GI) monitoring technology.
 |
 |
DigeHealth has raised CHF 1.25 million in seed funding, which will accelerate its work on gastrointestinal (GI) health solutions. The funding will allow the medtech startup to develop its next-generation GI monitoring technology.
Designed to provide continuous, objective insights, this solution aims to transform care for patients with common and complex digestive disorders, including Irritable Bowel Syndrome (IBS), Inflammatory Bowel Diseases (IBD), and bowel obstructions. By delivering more precise and actionable data, DigeHealth’s technology seeks to improve diagnosis, treatment, and patient outcomes in ways previously unattainable.
The medtech startup has participated in Venture Leaders Medtech and received backing by Venture Kick. “Venturelab supported us at two key inflection points—first at the ideation stage through early financing, and later this year through the Venture Leaders Medtech program." highlighted CEO Nour Ghalia Abassi. "Both programs, Venture Kick and Venture Leaders, helped shape the trajectory of DigeHealth. The role Venturelab plays in the entrepreneurial ecosystem is fundamental for Swiss early-stage startups, it is a true proving ground where founders are forged.”
DigeHealth team: Nour Ghalia Abassi, Till Gerken, and Christian Frei
Designed to provide continuous, objective insights, this solution aims to transform care for patients with common and complex digestive disorders, including Irritable Bowel Syndrome (IBS), Inflammatory Bowel Diseases (IBD), and bowel obstructions. By delivering more precise and actionable data, DigeHealth’s technology seeks to improve diagnosis, treatment, and patient outcomes in ways previously unattainable.
The medtech startup has participated in Venture Leaders Medtech and received backing by Venture Kick. “Venturelab supported us at two key inflection points—first at the ideation stage through early financing, and later this year through the Venture Leaders Medtech program." highlighted CEO Nour Ghalia Abassi. "Both programs, Venture Kick and Venture Leaders, helped shape the trajectory of DigeHealth. The role Venturelab plays in the entrepreneurial ecosystem is fundamental for Swiss early-stage startups, it is a true proving ground where founders are forged.”
DigeHealth team: Nour Ghalia Abassi, Till Gerken, and Christian Frei